Identification_NN of_IN Anaplasma_NP phagocytophila_NP (_( Formerly_NP Ehrlichia_NP phagocytophila_NN )_) Variants_NP in_IN Blood_NP from_IN Sheep_NP in_IN Norway_NP A_DT total_NN of_IN 41_CD blood_NN samples_NNS were_VBD collected_VBN from_IN 40_CD Anaplasma_NP phagocytophila-infected_JJ sheep_NN in_IN 11_CD sheep_NN flocks_VBZ from_IN four_CD different_JJ counties_NNS of_IN southern_JJ Norway_NP ._SENT The_DT presence_NN and_CC nature_NN of_IN the_DT Anaplasma_NP species_NN were_VBD identified_VBN by_IN microscopic_JJ detection_NN of_IN morulae_NNS ,_, PCR_NP ,_, reverse_JJ line_NN blot_NN hybridization_NN ,_, and_CC 16S_JJ rRNA_NN gene_NN sequencing_NP ._SENT A._NP phagocytophila_NN was_VBD identified_VBN in_IN all_DT of_IN the_DT samples_NNS ,_, and_CC sequencing_VBG of_IN the_DT 16S_JJ rRNA_NN gene_NN revealed_VBD the_DT presence_NN of_IN four_CD variants_NNS of_IN A._NP phagocytophila_NN ._SENT Two_CD of_IN these_DT variants_NNS have_VBP been_VBN described_VBN before_IN ,_, but_CC two_CD were_VBD newly_RB identified_VBN 16S_JJ rRNA_NN variants_NNS of_IN this_DT species_NN ._SENT A._NP phagocytophila_NNS variant_JJ 1_CD was_VBD found_VBN in_IN nine_CD flocks_VBZ ,_, A._NP phagocytophila_NNS variant_JJ 2_CD was_VBD found_VBN in_IN four_CD flocks_VBZ ,_, the_DT A._NP phagocytophila_NN prototype_NN was_VBD found_VBN in_IN two_CD flocks_VBZ ,_, and_CC A._NP phagocytophila_NNS variant_JJ 5_CD was_VBD found_VBN in_IN one_CD flock_NN ._SENT In_IN two_CD flocks_VBZ ,_, some_DT sheep_NN were_VBD infected_VBN with_IN A._NP phagocytophila_NN variant_NN 1_CD ,_, whereas_IN others_NNS were_VBD infected_VBN with_IN A._NP phagocytophila_NN variant_NN 2_CD ,_, and_CC in_IN three_CD animals_NNS a_DT double_JJ infection_NN with_IN two_CD variants_NNS was_VBD registered_VBN ._SENT Analyses_NNS of_IN the_DT blood_NN samples_NNS revealed_VBD that_DT blood_NN from_IN sheep_NN infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 2_CD contained_VBD nearly_RB twice_RB as_IN many_JJ neutrophils_NNS and_CC eight_CD times_NNS as_IN many_JJ Anaplasma-infected_JJ neutrophils_NNS as_IN blood_NN from_IN sheep_NN infected_VBN with_IN the_DT A._NP phagocytophila_NN variant_JJ 1_CD ._SENT Furthermore_RB ,_, only_RB 43_CD %_NN of_IN the_DT A._NP phagocytophila_NN variant_NN 2-infected_JJ sheep_NN displayed_VBD antibody_NN responses_NNS in_IN an_DT immune_JJ fluorescence_NN assay_NN ,_, whereas_IN 93_CD %_NN of_IN the_DT sheep_NN with_IN the_DT A._NP phagocytophila_NN variant_NN 1-infected_JJ sheep_NN were_VBD seropositive_JJ ._SENT Tick-borne_NP fever_NN (_( TBF_NP )_) in_IN sheep_NN caused_VBN by_IN Ehrlichia_NP phagocytophila_NN and_CC transmitted_VBN by_IN the_DT tick_NN Ixodes_NP ricinus_NN was_VBD the_DT first_JJ granulocytic_JJ ehrlichial_JJ infection_NN to_TO be_VB described_VBN and_CC has_VBZ for_IN decades_NNS been_VBN a_DT well-known_JJ disease_NN in_IN domestic_JJ ruminants_NNS in_IN several_JJ countries_NNS in_IN Europe_NP ._SENT E._NP phagocytophila_NP belongs_VBZ to_TO the_DT same_JJ genogroup_NN as_IN Ehrlichia_NP equi_NP and_CC human_JJ granulocytic_JJ ehrlichiosis_NN (_( HGE_NP )_) agent_NN ,_, and_CC natural_JJ infection_NN with_IN granulocytic_JJ Ehrlichia_NP has_VBZ now_RB been_VBN reported_VBN in_IN a_DT variety_NN of_IN animal_JJ species_NNS ._SENT Recently_RB ,_, Dumler_NP et_FW al._FW reorganized_VBN the_DT families_NNS Rickettsiaceae_NP and_CC Anaplasmataceae_NP ,_, and_CC E._NP phagocytophila_NP ,_, E._NP equi_NP ,_, and_CC the_DT HGE_NP agent_NN were_VBD unified_VBN into_IN the_DT new_JJ species_NN combination_NN Anaplasma_NP phagocytophila_NN ._SENT For_IN this_DT reason_NN we_PP use_VBP A._NP phagocytophila_NN as_IN the_DT emended_VBN name_NN for_IN this_DT species_NN throughout_IN this_DT study_NN ._SENT TBF_NP is_VBZ a_DT common_JJ disease_NN in_IN domestic_JJ ruminants_NNS along_IN the_DT coast_NN of_IN southern_JJ Norway_NP ._SENT In_IN 1995_CD ,_, more_JJR than_IN 11,000_CD sheep_NN flocks_VBZ were_VBD treated_VBN prophylactically_RB against_IN TBF_NP with_IN tick_NN repellent_NN and/or_CC insecticides_NNS ,_, including_VBG ca_MD ._SENT 40_CD %_NN of_IN all_DT flocks_VBZ in_IN Norway_NP ._SENT In_IN sheep_NN ,_, TBF_NP is_VBZ characterized_VBN by_IN high_JJ fever_NN ,_, reduced_VBN milk_NN yield_NN ,_, abortion_NN ,_, and_CC reduced_VBN fertility_NN in_IN rams_NNS ._SENT The_DT diagnosis_NN was_VBD earlier_RBR based_VBN on_IN the_DT presence_NN of_IN inclusions_NNS (_( morulae_NNS )_) in_IN circulating_VBG neutrophils_NNS in_IN Giemsa-stained_JJ blood_NN smears_NNS ._SENT A._NP phagocytophila_NN infection_NN in_IN sheep_NN is_VBZ known_VBN to_TO produce_VB profound_JJ effects_NNS on_IN the_DT immunological_JJ defense_NN system_NN ,_, which_WDT increases_VBZ susceptiblility_NN to_TO disease_NN and_CC mortality_NN from_IN intercurrent_JJ infections_NNS such_JJ as_IN Staphylococcus_NP aureus_NN pyaemia_NN and_CC Pasteurella_NP haemolytica/trehalosi_NP septicemia_NN ._SENT Sheep_NP flocks_VBZ may_MD suffer_VB heavily_RB on_IN I._NP ricinus-infested_JJ pastures_NNS both_CC due_JJ to_TO direct_VB mortality_NN and_CC to_TO impairment_NN of_IN growth_NN rate_NN and_CC production_NN ._SENT In_IN one_CD flock_NN investigated_VBN in_IN Norway_NP ,_, almost_RB one-third_JJ of_IN the_DT lambs_NNS died_VBN on_IN Ixodes-infested_JJ pastures_NNS due_JJ to_TO TBF_NP and_CC secondary_JJ infections_NNS ._SENT Lamb_NP losses_NNS on_IN I._NP ricinus-infested_JJ pastures_NNS may_MD vary_VB considerably_RB between_IN neighboring_JJ farms_NNS ._SENT The_DT reasons_NNS for_IN these_DT variations_NNS are_VBP unknown_JJ but_CC may_MD be_VB caused_VBN by_IN differences_NNS in_IN virulence_NN between_IN variants_NNS of_IN Anaplasma_NP ._SENT Such_JJ variations_NNS have_VBP earlier_RBR been_VBN found_VBN in_IN both_DT sheep_NN and_CC cattle_NNS ._SENT The_DT identification_NN of_IN Anaplasma_NP and_CC Ehrlichia_NP species_NN is_VBZ difficult_JJ because_IN conventional_JJ bacteriological_JJ methods_NNS for_IN cultivation_NN and_CC characterization_NN cannot_MD be_VB used_VBN ._SENT Morphological_JJ and_CC serological_JJ methods_NNS are_VBP also_RB unreliable_JJ to_TO differentiate_VB Anaplasma_NP and_CC Ehrlichia_NP species_NNS due_JJ to_TO morphological_JJ similarities_NNS and_CC antigen_NN cross-reactivity_NN between_IN species_NNS ._SENT The_DT purpose_NN of_IN the_DT present_JJ study_NN was_VBD therefore_RB to_TO identify_VB and_CC compare_VB Anaplasma_NP species_NNS from_IN sheep_NN with_IN TBF_NP from_IN different_JJ areas_NNS of_IN Norway_NP by_IN molecular_JJ methods_NNS ._SENT In_IN addition_NN ,_, we_PP wanted_VBD to_TO study_VB the_DT number_NN of_IN neutrophils_NNS ,_, their_PP$ infection_NN rate_NN ,_, and_CC the_DT antibody_NN response_NN in_IN infected_JJ sheep_NN ._SENT Animals_NNS ,_, blood_NN samples_NNS ,_, and_CC hematology_NN ._SENT |_SYM Blood_NP samples_NNS were_VBD collected_VBN from_IN Norwegian_JJ sheep_NN with_IN TBF_NP in_IN different_JJ I._NP ricinus-infested_JJ areas_NNS in_IN Norway_NP ._SENT A_DT number_NN of_IN collaborating_VBG sheep_NN farmers_NNS were_VBD informed_VBN before_IN the_DT tick_NN season_NN ,_, and_CC they_PP were_VBD instructed_VBN to_TO contact_VB the_DT local_JJ veterinarian_NN for_IN blood_NN sampling_NN when_WRB a_DT suspected_JJ case_NN of_IN TBF_NP was_VBD found_VBN in_IN their_PP$ flocks_VBZ ._SENT TBF_NP had_VBD earlier_RBR caused_VBN high_JJ mortality_NN in_IN all_DT of_IN these_DT flocks_VBZ ,_, except_IN in_IN one_CD flock_NN (_( flock_NN D_NP ;_: see_VBP below_IN and_CC Table_NP )_) ._SENT The_DT rectal_JJ temperatures_NNS of_IN the_DT actual_JJ sheep_NN were_VBD measured_VBN ,_, and_CC whole_JJ blood_NN and_CC EDTA-blood_NN samples_NNS were_VBD collected_VBN and_CC sent_VBN to_TO the_DT Department_NP of_IN Sheep_NP and_CC Goat_NP Research_NP for_IN further_JJR analyses_NNS ._SENT No_DT further_JJR information_NN of_IN the_DT animals_NNS was_VBD available_JJ after_IN blood_NN sampling_NN ._SENT Hematological_JJ values_NNS ,_, including_VBG total_JJ and_CC differential_JJ leukocyte_NN counts_NNS ,_, were_VBD determined_VBN electronically_RB from_IN the_DT EDTA-blood_NP samples_NNS (_( Technicon_NP H1_NP ;_: Miles_NP ,_, Inc._NP )_) ,_, and_CC blood_NN smears_NNS were_VBD prepared_VBN and_CC stained_VBN with_IN May-Grunwald_NP Giemsa_NP ._SENT A_DT total_NN of_IN 400_CD neutrophils_NNS were_VBD examined_VBN on_IN each_DT smear_NN by_IN microscopy_NN ;_: the_DT numbers_NNS of_IN cells_NNS containing_VBG Anaplasma_NP inclusions_NNS were_VBD recorded_VBN ,_, and_CC the_DT percentages_NNS of_IN infected_JJ neutrophilic_JJ granulocytes_NNS were_VBD calculated_VBN ._SENT The_DT rest_NN of_IN the_DT EDTA-blood_NP was_VBD frozen_VBN at_IN -20C_NN until_IN further_JJR analyses_NNS could_MD be_VB performed_VBN ._SENT Serology_NN ._SENT |_SYM Serum_NP samples_NNS were_VBD analyzed_VBN for_IN the_DT presence_NN of_IN antibodies_NNS to_TO Anaplasma_NP by_IN an_DT indirect_JJ immunofluorescence_NN antibody_NN assay_NN ._SENT Briefly_RB ,_, twofold_JJ dilutions_NNS of_IN sera_NN were_VBD added_VBN to_TO slides_NNS precoated_VBN with_IN E._NP equi_NP antigen_NN (_( Protatek_NP ,_, St._NP Paul_NP ,_, Minn._NP )_) ._SENT Bound_JJ antibodies_NNS were_VBD visualized_VBN by_IN fluorescein-isothiocyanate-conjugated_JJ rabbit_NN anti-sheep_NN immunoglobulin_NN (_( Cappel_NP ;_: Organon_NP Teknika_NP ,_, West_NP Chester_NP ,_, Pa._NP )_) ._SENT Sera_NP were_VBD screened_VBN for_IN antibodies_NNS at_IN a_DT dilution_NN of_IN 1:40_CD ._SENT If_IN positive_JJ ,_, the_DT serum_NN was_VBD further_RBR diluted_VBN and_CC retested_VBN ._SENT A_DT titer_NN of_IN 1.6_CD (_( log10_NN reciprocal_NN of_IN 1:40_CD )_) or_CC more_JJR was_VBD regarded_VBN positive_JJ ._SENT DNA_NP extraction_NN and_CC PCR_NP amplification_NN ._SENT |_SYM DNA_NN extraction_NN on_IN blood_NN samples_NNS was_VBD performed_VBN according_VBG to_TO Olsson_NP Engvall_NP et_FW al._FW ,_, with_IN some_DT modifications_NNS ._SENT Briefly_RB ,_, 400_CD mul_NN of_IN thawed_VBN EDTA-blood_NP was_VBD treated_VBN with_IN 220_CD mul_NN of_IN cold_JJ lysis_NN buffer_NN (_( 10_CD mM_NP Tris-HCl_NP [_SYM pH_NN 7.4_CD ]_SYM ,_, 100_CD mM_NP EDTA_NP )_) ,_, 0.5_CD %_NN sodium_NN dodecyl_NN sulfate_NN ,_, and_CC 10_CD mul_NN of_IN proteinase_NN K_NP (_( 20_CD mg/ml_NN )_) and_CC then_RB mixed_VBN gently_RB and_CC incubated_VBN at_IN 50C_NN for_IN 2_CD h._NNS The_DT mixture_NN was_VBD mingled_VBN every_DT 15_CD min_NN ,_, and_CC after_IN 1_CD h_NN another_DT 6_CD mul_NN of_IN proteinase_NN K_NP (_( 20_CD mg/ml_NN )_) was_VBD added_VBN ._SENT The_DT mixture_NN was_VBD then_RB extracted_VBN twice_RB with_IN an_DT equal_JJ volume_NN of_IN phenol-chloroform-isoamyl_NN alcohol_NN (_( 25:24:1_CD )_) and_CC once_RB with_IN an_DT equal_JJ volume_NN of_IN chloroform-isoamyl_NN alcohol_NN (_( 24:1_CD )_) ._SENT DNA_NP was_VBD precipitated_VBN by_IN the_DT addition_NN of_IN a_DT 1/10_CD volume_NN of_IN 2_CD M_NP sodium_NN acetate_NN (_( pH_NN 6.5_CD )_) and_CC 2.5_CD volumes_NNS of_IN cold_JJ ethanol_NN (_( 99_CD %_NN )_) and_CC was_VBD then_RB collected_VBN by_IN centrifugation_NN ._SENT The_DT pellet_NN was_VBD washed_VBN once_RB in_IN cold_JJ ethanol_NN (_( 70_CD %_NN )_) ,_, dried_VBD ,_, and_CC resuspended_VBD in_IN 50_CD mul_NN of_IN sterile_JJ water_NN ,_, and_CC the_DT DNA_NP concentration_NN was_VBD then_RB measured_VBN with_IN a_DT spectrophotometer_NN (_( GeneQuant_NP II_NP ;_: Pharmacia_NP Biotech_NP ,_, Uppsala_NP ,_, Sweden_NP )_) ._SENT PCR_NP amplifications_NNS were_VBD performed_VBN in_IN a_DT GeneAmp_NP PCR_NP system_NN 9700_CD thermal_JJ cycler_NN (_( Applied_NP Biosystems_NP ,_, Nieuwerkerk_NP a/d_NNS Ijssel_NP ,_, The_DT Netherlands_NPS )_) ._SENT The_DT 5_CD '_POS part_NN of_IN the_DT 16S_JJ rRNA_NN gene_NN of_IN the_DT Anaplasma_NP species_NN in_IN the_DT sheep_NN blood_NN samples_NNS were_VBD amplified_VBN in_IN 50-mul_NN volumes_NNS consisting_VBG of_IN 25_CD mul_NN of_IN HotStarTaq_NP mix_NN (_( Qiagen_NP ,_, Hilden_NP ,_, Germany_NP )_) ,_, 4_CD mul_NN of_IN primer_JJR 16S8FE_JJ (_( 80_CD pmol_NN )_) ,_, 4_CD mul_NN of_IN primer_NN B-GA1B_NP (_( 80_CD pmol_NN )_) ,_, 2_CD mul_NN of_IN tmpB_NN spike_NN DNA_NN (_( 10_CD fg_NN )_) ,_, 10_CD mul_NN of_IN water_NN ,_, and_CC 5_CD mul_NN of_IN DNA_NN sample_NN ._SENT To_TO minimize_VB nonspecific_JJ amplification_NN ,_, a_DT touchdown-up_JJ PCR_NP program_NN was_VBD used_VBN :_: 15_CD min_NN at_IN 94C_NN ,_, followed_VBN by_IN two_CD cycles_NNS of_IN 20_CD s_NNS at_IN 94C_NN ,_, 30_CD s_NNS at_IN 65C_JJ ,_, and_CC 30_CD s_NNS at_IN 72C_NP ;_: followed_VBN by_IN two_CD cycles_NNS under_IN conditions_NNS identical_JJ to_TO the_DT previous_JJ cycles_NNS but_CC with_IN an_DT annealing_VBG temperature_NN of_IN 63C_JJ ._SENT During_IN subsequent_JJ two_CD cycle_NN sets_NNS ,_, the_DT annealing_VBG temperature_NN was_VBD lowered_VBN by_IN 2C_JJ until_IN it_PP reached_VBD 55C_NN ._SENT We_PP then_RB carried_VBD out_RP an_DT additional_JJ 20_CD cycles_NNS of_IN 20_CD s_NNS at_IN 94C_NN ,_, 30_CD s_NNS at_IN 55C_NN ,_, and_CC 30_CD s_NNS at_IN 72C_NP ,_, followed_VBN by_IN 20_CD cycles_NNS of_IN 20_CD s_NNS at_IN 94C_NN ,_, 30_CD s_NNS at_IN 63C_JJ ,_, and_CC 30_CD s_NNS at_IN 72C_NP ,_, followed_VBD again_RB by_IN the_DT touchdown_NN program_NN ._SENT The_DT PCR_NP was_VBD ended_VBN by_IN an_DT extra_JJ incubation_NN for_IN 7_CD min_NN at_IN 72C_NP ._SENT Each_DT time_NN that_IN the_DT PCR_NP was_VBD performed_VBN ,_, negative_JJ (_( no_DT sample_NN added_VBD )_) and_CC positive_JJ (_( Anaplasma_NP or_CC Ehrlichia_NP DNA_NP )_) control_NN samples_NNS were_VBD included_VBN ._SENT Each_DT sample_NN was_VBD spiked_VBN with_IN a_DT critical_JJ amount_NN (_( 150_CD copies_NNS )_) of_IN the_DT tmpB_NN spike_NN control_NN DNA_NN to_TO detect_VB any_DT inhibition_NN of_IN the_DT PCR_NP that_WDT might_MD lead_VB to_TO false-negative_JJ results_NNS ._SENT When_WRB a_DT relatively_RB high_JJ concentration_NN of_IN Anaplasma_NP DNA_NP was_VBD available_JJ ,_, the_DT spike_NN was_VBD weak_JJ or_CC absent_JJ ._SENT In_IN order_NN to_TO minimize_VB contamination_NN ,_, the_DT reagent_NN setup_NN ,_, the_DT sample_NN addition_NN ,_, and_CC the_DT PCR_NP and_CC sample_NN analysis_NN were_VBD performed_VBN in_IN three_CD separate_JJ rooms_NNS ,_, of_IN which_WDT the_DT first_JJ two_CD rooms_NNS were_VBD kept_VBN at_IN a_DT positive_JJ pressure_NN and_CC had_VBD airlocks_NNS ._SENT Reverse_JJ line_NN blot_NN hybridization_NN ._SENT |_SYM The_DT reverse_JJ line_NN blotting_VBG technique_NN has_VBZ been_VBN described_VBN before_RB ._SENT Briefly_RB ,_, solutions_NNS with_IN 5_CD '_POS amino-linked_JJ oligonucleotide_NN probes_NNS were_VBD coupled_VBN covalently_RB to_TO an_DT activated_VBN Biodyne_NP C_NP membrane_NN in_IN a_DT line_NN pattern_NN by_IN using_VBG a_DT miniblotter_NN (_( Immunetics_NP ,_, Cambridge_NP ,_, Mass._NP )_) ._SENT After_IN binding_VBG of_IN the_DT oligonucleotide_NN probes_NNS ,_, the_DT membrane_NN was_VBD taken_VBN from_IN the_DT miniblotter_NN ,_, washed_VBN ,_, and_CC again_RB placed_VBN in_IN the_DT miniblotter_NN with_IN the_DT oligonucleotide_NN lines_NNS perpendicular_JJ to_TO the_DT slots_NNS ._SENT The_DT slots_NNS of_IN the_DT miniblotter_NN were_VBD filled_VBN with_IN the_DT biotin-labeled_NN denatured_VBN PCR_NP product_NN ,_, and_CC hybridization_NN was_VBD performed_VBN ._SENT The_DT membrane_NN was_VBD removed_VBN from_IN the_DT miniblotter_NN ,_, washed_VBN ,_, and_CC subsequently_RB incubated_VBN with_IN streptavidin-peroxidase_NN to_TO detect_VB bound_JJ biotin-labeled_JJ PCR_NP product_NN ._SENT After_IN a_DT washing_NN step_NN ,_, hybridization_NN was_VBD visualized_VBN by_IN incubating_VBG the_DT membrane_NN with_IN enhanced_JJ chemiluminescence_NN detection_NN liquid_NN (_( Amersham_NP International_NP ,_, plc_NN ._SENT ,_, Den_NP Bosch_NP ,_, The_DT Netherlands_NPS )_) and_CC exposing_VBG the_DT membrane_NN to_TO X-ray_VB film_NN ._SENT For_IN species_NN identification_NN ,_, the_DT biotinylated_JJ PCR_NP product_NN was_VBD hybridized_VBN with_IN 10_CD different_JJ Anaplasma-_NP and_CC Ehrlichia-specific_NP oligonucleotide_NN probes_NNS in_IN the_DT reverse_JJ line_NN blot_NN assay_NN ._SENT All_DT primers_NNS and_CC probes_NNS are_VBP described_VBN in_IN Table_NP ._SENT DNA_NP sequencing_NP and_CC data_NNS analysis_NN ._SENT |_SYM Most_JJS PCR_NP products_NNS were_VBD used_VBN directly_RB for_IN sequencing_VBG ,_, but_CC some_DT were_VBD cloned_VBN into_IN a_DT TA-TOPO_NP vector_NN (_( Invitrogen_NP ,_, Groningen_NP ,_, The_DT Netherlands_NPS )_) ._SENT The_DT plasmids_NNS were_VBD isolated_VBN and_CC purified_VBN by_IN using_VBG the_DT Qiagen_NP plasmid_NP minikit_NN and_CC used_VBN for_IN sequencing_NP ._SENT The_DT PCR_NP products_NNS used_VBN for_IN DNA_NP sequencing_NP were_VBD purified_VBN with_IN QiaQuick_NP PCR_NP purification_NN kits_NNS (_( Qiagen_NP )_) ._SENT Since_IN PCR_NP products_NNS were_VBD obtained_VBN in_IN a_DT PCR_NP that_WDT included_VBD a_DT spike_NN control_NN ,_, the_DT PCR_NP yielded_VBD a_DT mixture_NN of_IN Anaplasma_NP PCR_NP product_NN and_CC the_DT tmpB_NN spike_NN ._SENT Therefore_RB ,_, we_PP used_VBD sequence_NN primers_NNS that_WDT were_VBD specific_JJ for_IN the_DT Anaplasma_NP PCR_NP product_NN only_RB (_( 16SEhrSeq_NP and_CC GA1BSeq_NP )_) ._SENT For_IN DNA_NP sequencing_NP reactions_NNS ,_, the_DT fluorescence-labeled_JJ dideoxynucleotide_NN technology_NN was_VBD used_VBN (_( Perkin-Elmer_NP ,_, Applied_NP Biosystems_NP Division_NP )_) ._SENT The_DT sequenced_JJ fragments_NNS were_VBD separated_VBN ,_, and_CC data_NNS were_VBD collected_VBN with_IN an_DT ABI_NP 3700_CD automated_JJ DNA_NN sequencer_NN (_( ABI_NP ,_, Applied_NP Biosystems_NP Division_NP )_) ._SENT The_DT collected_VBN sequences_NNS were_VBD assembled_VBN ,_, edited_VBN ,_, and_CC analyzed_VBD with_IN the_DT DNAStar_NP package_NN (_( DNAStar_NP ,_, Inc._NP ,_, Madison_NP ,_, Wis._NP )_) ._SENT Statistics_NNS ._SENT |_SYM Statistical_NP calculations_NNS on_IN seroprevalences_NNS were_VBD performed_VBN by_IN using_VBG the_DT chi-square_NN contingency_NN test_NN ,_, and_CC a_DT two-sample_JJ t_NN test_NN was_VBD used_VBN for_IN the_DT hematological_JJ variables_NNS and_CC the_DT antibody_NN titers_NNS (_( Statistix_NP ,_, version_NN 4.0_CD ;_: Analytical_NP Software_NP )_) ._SENT A_DT P_NN value_NN of_IN <0.05_NN was_VBD considered_VBN significant_JJ ._SENT Nucleotide_NN sequence_NN accession_NN number_NN ._SENT |_SYM The_DT 16S_JJ rRNA_NN gene_NN sequences_NNS of_IN the_DT new_JJ variants_NNS of_IN A._NP phagocytophila_NN found_VBD in_IN the_DT present_JJ study_NN are_VBP available_JJ in_IN the_DT GenBank_NP database_NN under_IN the_DT accession_NN numbers_NNS and_CC ._SENT TABLE_NN 3_CD |_SYM A._NP phagocytophila_NN variants_NNS from_IN 11_CD sheep_NN flocks_VBZ in_IN Norway_NP identified_VBN by_IN reverse_JJ line_NN blot_NN hybridization_NN and_CC DNA_NN sequencing_VBG TABLE_NP 1_CD |_SYM Oligonucleotide_NN primers_NNS and_CC probes_NNS used_VBN in_IN PCRs_NN and_CC hybridization_NN assays_NNS Blood_NP samples_NNS ._SENT |_SYM Altogether_RB 41_CD blood_NN samples_NNS from_IN 40_CD different_JJ sheep_NN were_VBD collected_VBN ._SENT Two_CD samples_NNS originated_VBN from_IN the_DT same_JJ sheep_NN and_CC were_VBD drawn_VBN 1_CD month_NN apart_RB ._SENT All_DT sampled_VBN sheep_NN revealed_VBD clinical_JJ signs_NNS of_IN TBF_NP ,_, such_JJ as_IN fever_NN ,_, increased_VBN respiration_NN ,_, dullness_NN ,_, and_CC inappetence_NN ._SENT Concurrent_JJ diseases_NNS were_VBD not_RB observed_VBN ._SENT The_DT samples_NNS were_VBD from_IN 11_CD sheep_NN flocks_VBZ in_IN four_CD different_JJ counties_NNS of_IN southern_JJ Norway_NP and_CC were_VBD collected_VBN from_IN April_NP to_TO October_NP in_IN two_CD consecutive_JJ years_NNS ._SENT The_DT age_NN of_IN the_DT sheep_NN varied_VBN from_IN 1_CD month_NN to_TO 2_CD years_NNS ;_: however_RB ,_, most_JJS of_IN the_DT animals_NNS (_( 68_CD %_NN )_) were_VBD less_JJR than_IN 4_CD months_NNS old_JJ ._SENT Reverse_JJ blot_NN line_NN hybridization_NN and_CC DNA_NN sequence_NN analysis_NN ._SENT |_SYM In_IN order_NN to_TO confirm_VB the_DT results_NNS observed_VBD by_IN the_DT reverse_JJ line_NN blot_NN assay_NN ,_, the_DT PCR_NP products_NNS used_VBN in_IN hybridizations_NNS were_VBD also_RB sequenced_JJ ._SENT Although_IN the_DT sequence_NN analysis_NN largely_RB confirmed_VBD the_DT reverse_JJ line_NN blot_NN results_NNS ,_, additional_JJ sequence_NN variation_NN was_VBD found_VBN ._SENT The_DT blood_NN samples_NNS carried_VBD A._NP phagocytophila_NN that_WDT displayed_VBD minor_JJ sequence_NN variation_NN of_IN the_DT 16S_JJ rRNA_NN gene_NN and_CC were_VBD designated_VBN variants_NNS ._SENT Two_CD samples_NNS carried_VBD 16S_JJ rRNA_NN gene_NN sequences_NNS identical_JJ to_TO the_DT A._NP phagocytophila_NN prototype_NN (_( GenBank_NP accession_NN no_RB ._SENT )_) and_CC a_DT second_JJ group_NN carried_VBD 16S_JJ sequences_NNS identical_JJ to_TO the_DT sequence_NN with_IN the_DT accession_NN number_NN that_WDT differed_VBD at_IN nucleotide_NN position_NN 80_CD from_IN the_DT prototype_NN sequence_NN and_CC was_VBD designated_VBN variant_JJ 1_CD ._SENT The_DT largest_JJS group_NN of_IN sheep_NN carried_VBN A._NP phagocytophila_NN that_WDT differed_VBD at_IN positions_NNS 80_CD and_CC 100_CD of_IN the_DT 16S_JJ rRNA_NN gene_NN ,_, and_CC this_DT type_NN was_VBD designated_VBN A._NP phagocytophila_NN variant_NN 2_CD (_( accession_NN no_RB ._SENT )_) ._SENT One_CD sample_NN contained_VBD the_DT new_JJ A._NP phagocytophila_NN variant_NN 5_CD ,_, which_WDT differed_VBD at_IN position_NN 93_CD of_IN the_DT 16S_JJ gene_NN (_( accession_VB no_RB ._SENT )_) ._SENT The_DT prototype_NN and_CC all_DT variant_JJ signature_NN sequences_NNS ,_, including_VBG some_DT other_JJ published_JJ sequences_NNS ,_, are_VBP displayed_VBN in_IN Table_NP ._SENT A_DT probe_NN was_VBD designed_VBN to_TO detect_VB the_DT A._NP phagocytophila_NN variant_NN 2_CD ,_, and_CC all_DT samples_NNS were_VBD retested_VBN on_IN a_DT reverse_JJ line_NN blot_NN that_WDT included_VBD this_DT probe_NN ._SENT This_DT analysis_NN was_VBD in_IN complete_JJ concordance_NN with_IN the_DT sequence_NN analysis_NN and_CC confirmed_VBD that_IN the_DT observed_JJ sequence_NN variation_NN was_VBD not_RB an_DT artifact_NN introduced_VBN by_IN the_DT sequencing_VBG procedure_NN ._SENT When_WRB blood_NN samples_NNS from_IN a_DT total_NN of_IN 11_CD sheep_NN flocks_VBZ were_VBD examined_VBN ,_, A._NP phagocytophila_NNS variant_JJ 1_CD was_VBD found_VBN in_IN nine_CD flocks_VBZ ,_, A._NP phagocytophila_NNS variant_JJ 2_CD was_VBD found_VBN in_IN four_CD flocks_VBZ ,_, A._NP phagocytophila_NN prototype_NN was_VBD found_VBN in_IN two_CD flocks_VBZ ,_, and_CC A.phagocytophila_NP variant_NN 5_CD was_VBD found_VBN in_IN one_CD flock_NN ._SENT In_IN two_CD flocks_VBZ ,_, some_DT sheep_NN were_VBD infected_VBN with_IN A._NP phagocytophila_NN variant_NN 1_CD ,_, whereas_IN others_NNS were_VBD infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 2_CD ._SENT In_IN three_CD animals_NNS the_DT PCR_NP product_NN reacted_VBD with_IN two_CD different_JJ Anaplasma_NP probes_NNS in_IN the_DT reverse_JJ line_NN blot_NN ,_, which_WDT might_MD indicate_VB a_DT double_JJ infection_NN with_IN two_CD different_JJ variants_NNS ._SENT DNA_NP sequencing_NP of_IN these_DT PCR_NP products_NNS revealed_VBD ambiguous_JJ bases_NNS at_IN a_DT few_JJ positions_NNS in_IN the_DT sequence_NN ,_, supporting_VBG the_DT supposition_NN that_IN double_JJ infection_NN with_IN two_CD variants_NNS had_VBD occurred_VBN ._SENT For_IN this_DT reason_NN the_DT PCR_NP products_NNS were_VBD cloned_VBN into_IN a_DT plasmid_NN ,_, and_CC the_DT inserts_NNS of_IN 10_CD clones_NNS of_IN each_DT cloned_VBN PCR_NP product_NN were_VBD sequenced_JJ ._SENT This_DT indeed_RB revealed_VBN the_DT simultaneous_JJ presence_NN of_IN two_CD different_JJ variants_NNS in_IN these_DT three_CD animals_NNS ._SENT Both_DT samples_NNS of_IN the_DT one_CD animal_NN that_WDT was_VBD sampled_VBN twice_RB carried_VBD the_DT same_JJ variant_NN of_IN A._NP phagocytophila_NN ._SENT In_IN one_CD flock_NN ,_, where_WRB 21_CD animals_NNS were_VBD examined_VBN ,_, 3_CD (_( 14_CD %_NN )_) were_VBD infected_VBN with_IN A._NP phagocytophila_NN variant_NN 1_CD ,_, and_CC 18_CD (_( 86_CD %_NN )_) were_VBD infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 2_CD ._SENT To_TO exclude_VB the_DT possibility_NN that_IN A._NP phagocytophila_NP carried_VBD two_CD different_JJ copies_NNS of_IN the_DT 16S_JJ rRNA_NN gene_NN ,_, we_PP performed_VBD a_DT Southern_JJ blot_NN hybridization_NN with_IN a_DT biotin-labeled_JJ 16S_JJ rRNA_NN oligonucleotide_NN probe_NN on_IN XbaI-_NP and_CC PstI-digested_NP genomic_JJ A._NP phagocytophila_NN DNA_NN ._SENT This_DT revealed_VBD the_DT presence_NN of_IN a_DT single_JJ 16S_JJ rRNA_NN gene_NN in_IN the_DT genome_NN (_( data_NNS not_RB shown_VBN )_) ._SENT This_DT result_NN was_VBD not_RB completely_RB unexpected_JJ since_IN BLAST_NN searches_NNS in_IN the_DT E._NP chaffeensis_NN genome_NN sequence_NN had_VBD also_RB shown_VBN that_IN this_DT Ehrlichia_NP species_NN contains_VBZ a_DT single_JJ 16S_JJ rRNA_NN gene_NN ._SENT Clinical_JJ parameters_NNS ,_, hematology_NN ,_, and_CC serology_NN ._SENT |_SYM Clinical_JJ variables_NNS at_IN the_DT time_NN of_IN blood_NN sampling_NN were_VBD obtained_VBN from_IN 37_CD sheep_NN ._SENT A_DT marked_JJ and_CC significant_JJ difference_NN was_VBD found_VBN in_IN the_DT number_NN of_IN neutrophils_NNS ._SENT Blood_NN samples_NNS from_IN sheep_NN infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 2_CD contained_VBD nearly_RB twice_RB as_IN many_JJ neutrophils_NNS as_IN blood_NN samples_NNS from_IN sheep_NN infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 1_CD ._SENT In_IN addition_NN ,_, blood_NN from_IN A._NP phagocytophila_NP variant_JJ 2-infected_JJ sheep_NN carried_VBD eight_CD times_NNS as_IN many_JJ neutrophils_NNS with_IN Anaplasma_NP inclusions_NNS as_IN blood_NN from_IN sheep_NN infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 1_CD ._SENT The_DT clinical_JJ parameters_NNS and_CC hematology_NN in_IN sheep_NN infected_VBN with_IN different_JJ variants_NNS of_IN granulocytic_JJ Anaplasma_NP are_VBP shown_VBN in_IN Table_NP ._SENT Antibody_NN titers_NNS to_TO E._NP equi_NNS measured_VBN at_IN the_DT day_NN of_IN blood_NN sampling_NN are_VBP shown_VBN in_IN Table_NP ._SENT Only_RB 24_CD of_IN 39_CD (_( 62_CD %_NN )_) of_IN the_DT acute_JJ Anaplasma-infected_JJ animals_NNS were_VBD found_VBN to_TO be_VB seropositive_JJ at_IN the_DT time_NN of_IN sampling_NN ._SENT Remarkably_RB ,_, 93_CD %_NN of_IN the_DT A._NP phagocytophila_NN variant_JJ 1-infected_JJ animals_NNS carried_VBD antibodies_NNS reacting_VBG with_IN the_DT E._NP equi_NN antigen_NN ,_, whereas_IN only_RB 43_CD %_NN of_IN the_DT sheep_NN infected_VBN with_IN A._NP phagocytophila_NNS variant_JJ 2_CD were_VBD seropositive_JJ (_( P_NN <_SYM 0.02_CD )_) ._SENT However_RB ,_, the_DT mean_JJ antibody_NN titer_NN (_( log10_NN )_) was_VBD not_RB significantly_RB different_JJ between_IN sheep_NN in_IN these_DT two_CD variant_JJ groups_NNS ._SENT FIG._NN 1_CD ._SENT |_SYM Reverse_NP blot_NN analysis_NN of_IN PCR_NP products_NNS obtained_VBN from_IN blood_NN samples_NNS of_IN A._NP phagocytophila_NP Reverse_NP blot_NN analysis_NN of_IN PCR_NP products_NNS obtained_VBN from_IN blood_NN samples_NNS of_IN A._NP phagocytophila-infected_JJ sheep_NN ._SENT The_DT oligonucleotide_NN probes_NNS are_VBP shown_VBN as_IN lines_NNS in_IN the_DT horizontal_JJ direction_NN ,_, and_CC the_DT biotin-labeled_JJ PCR_NP products_NNS are_VBP perpendicular_JJ in_IN the_DT vertical_JJ direction_NN ._SENT Samples_NNS 1_CD to_TO 3_CD ,_, samples_NNS from_IN A._NP phagocytophila_NP variant_JJ 1-infected_JJ sheep_NN ;_: samples_NNS 4_CD to_TO 8_CD ,_, samples_NNS from_IN A._NP phagocytophila_NP variant_JJ 2-infected_JJ sheep_NN ;_: B_NP ,_, blank_JJ controls_NNS (_( no_DT DNA_NN added_VBD )_) ;_: P_NN ,_, A._NP phagocytophila_NP prototype-positive_JJ PCR_NP control_NN ;_: V1_NP ,_, A._NP phagocytophila_NN variant_NN 1-positive_JJ PCR_NP control_NN ._SENT TABLE_NN 2_CD |_SYM The_DT 5_CD '_POS end_NN of_IN the_DT 16S_JJ rRNA_NN gene_NN sequences_NNS (_( bp_NN 81_CD to_TO 126_CD )_) of_IN different_JJ Anaplasma_NP and_CC Ehrlichia_NP strains_NNS were_VBD determined_VBN and_CC compared_VBN with_IN similar_JJ sequences_NNS from_IN GenBank_NP TABLE_NP 4_CD |_SYM Clinical_JJ variables_NNS (_( geometric_JJ mean_JJ +-_NN SD_NNS )_) and_CC antibody_NN titer_NN to_TO E._NP equi_NP antigen_NN in_IN 38_CD sheep_NN infected_VBN with_IN different_JJ variants_NNS of_IN A._NP phagocytophila_NN We_PP found_VBD four_CD 16S_JJ rRNA_NN gene_NN sequence_NN variants_NNS of_IN A._NP phagocytophila_NN in_IN blood_NN from_IN sheep_NN suffering_NN from_IN TBF_NP ._SENT To_TO our_PP$ knowledge_NN ,_, three_CD of_IN these_DT variants_NNS have_VBP not_RB earlier_RBR been_VBN identified_VBN in_IN sheep_NN ,_, and_CC two_CD of_IN them_PP have_VBP not_RB been_VBN identified_VBN in_IN any_DT other_JJ study_NN before_RB ._SENT Nucleotide_NN differences_NNS at_IN 16S_JJ rRNA_NN level_NN in_IN A._NP phagocytophila_NNS have_VBP been_VBN found_VBN in_IN isolates_NNS from_IN rodents_NNS ,_, deer_NN ,_, and_CC Ixodes_NP ticks_VBZ ._SENT However_RB ,_, whether_IN all_DT variants_NNS can_MD cause_VB disease_NN in_IN humans_NNS and_CC animals_NNS remains_VBZ to_TO be_VB determined_VBN ._SENT Therefore_RB ,_, the_DT importance_NN of_IN these_DT sequence_NN differences_NNS remains_VBZ to_TO be_VB elucidated_VBN ._SENT In_IN the_DT study_NN presented_VBD here_RB ,_, at_IN least_JJS two_CD of_IN the_DT variants_NNS found_VBN seem_VBP to_TO cause_VB classical_JJ A._NP phagocytophila_NN infection_NN in_IN sheep_NN ._SENT The_DT sampled_VBN sheep_NN were_VBD more_JJR than_IN 1_CD month_NN old_JJ ._SENT Age_NN resistance_NN in_IN lambs_NNS older_JJR than_IN 1_CD month_NN and_CC variation_NN in_IN clinical_JJ symptoms_NNS among_IN Norwegian_JJ sheep_NN breeds_NNS have_VBP not_RB been_VBN found_VBN in_IN experimentally_RB A._NP phagocytophila-infected_JJ lambs_NNS ._SENT In_IN the_DT present_JJ study_NN ,_, the_DT number_NN of_IN neutrophils_NNS ,_, the_DT number_NN of_IN infected_JJ neutrophils_NNS ,_, and_CC the_DT serological_JJ response_NN differed_VBD significantly_RB between_IN sheep_NN infected_VBN with_IN either_DT A._NP phagocytophila_NN variant_JJ 1_CD or_CC 2_CD ._SENT In_IN the_DT flock_NN with_IN few_JJ disease_NN problems_NNS ,_, 86_CD %_NN of_IN the_DT variants_NNS were_VBD of_IN the_DT A._NP phagocytophila_NN variant_NN 2_CD type_NN ._SENT One_CD possible_JJ reason_NN for_IN this_DT difference_NN could_MD be_VB that_IN the_DT A._NP phagocytophila_NN variant_JJ 2_CD is_VBZ better_RBR equipped_VBN to_TO elude_VB the_DT immune_JJ system_NN by_IN inhibiting_VBG antibody_NN response_NN ,_, resulting_VBG in_IN more_JJR proliferation_NN within_IN granulocytes_NNS ._SENT This_DT theory_NN is_VBZ supported_VBN by_IN the_DT observation_NN in_IN mice_NNS that_IN pathology_NN due_JJ to_TO host_NN immunity_NN seems_VBZ to_TO play_VB a_DT more_RBR important_JJ role_NN than_IN pathogenicity_NN of_IN Anaplasma_NP itself_PP during_IN infection_NN with_IN HGE_NP ._SENT However_RB ,_, the_DT role_NN of_IN host_NN immunity_NN in_IN the_DT pathogenesis_NN of_IN TBF_NP in_IN sheep_NN has_VBZ to_TO be_VB elucidated_VBN ._SENT Alternatively_RB ,_, the_DT differences_NNS in_IN morbidity_NN and_CC antibody_NN response_NN may_MD be_VB explained_VBN by_IN sampling_VBG in_IN the_DT later_JJR phase_NN of_IN the_DT infection_NN in_IN case_NN of_IN A._NP phagocytophila_NP variant_JJ 1-infected_JJ sheep_NN ._SENT However_RB ,_, later_JJR sampling_NN may_MD also_RB have_VB been_VBN caused_VBN by_IN less-apparent_JJ acute_JJ disease_NN manifestations_NNS in_IN the_DT A._NP phagocytophila_NN variant_JJ 2-infected_JJ animals_NNS ._SENT The_DT time_NN point_NN of_IN sampling_NN is_VBZ important_JJ since_IN earlier_JJR studies_NNS have_VBP shown_VBN that_IN ,_, in_IN the_DT later_JJR phase_NN of_IN the_DT acute_JJ infection_NN ,_, both_CC the_DT number_NN of_IN neutrophils_NNS and_CC the_DT rate_NN of_IN infected_JJ neutrophils_NNS decrease_VBP ._SENT Different_JJ clinical_JJ and_CC serological_JJ responses_NNS between_IN variants_NNS of_IN Anaplasma_NP have_VBP earlier_RBR been_VBN observed_VBN in_IN experimental_JJ infections_NNS in_IN cattle_NNS ,_, horses_NNS ,_, and_CC sheep_NN ._SENT In_IN the_DT present_JJ study_NN it_PP was_VBD difficult_JJ to_TO compare_VB different_JJ clinical_JJ and_CC serological_JJ values_NNS since_IN only_JJ single_JJ point_NN measurements_NNS were_VBD available_JJ ._SENT However_RB ,_, a_DT recent_JJ experimental_JJ inoculation_NN study_NN in_IN lambs_NNS of_IN a_DT single_JJ breed_NN revealed_VBD a_DT significant_JJ difference_NN in_IN the_DT clinical_JJ ,_, hematological_JJ ,_, and_CC serological_JJ responses_NNS between_IN these_DT two_CD variants_NNS of_IN A._NP phagocytophila_NP (_( S._NP Stuen_NP ,_, K._NP Bergstrom_NP ,_, M._NP Petrovec_NP ,_, I._NP Van_NP De_NP Pol_NP ,_, and_CC L._NP M._NP Schouls_NP ,_, unpublished_JJ data_NNS )_) ._SENT The_DT present_JJ serology_NN results_NNS indicate_VBP that_IN only_RB 61_CD %_NN of_IN the_DT acute_JJ Anaplasma-infected_JJ animals_NNS were_VBD seropositive_JJ at_IN the_DT time_NN of_IN sampling_NN ._SENT This_DT result_NN is_VBZ in_IN accordance_NN with_IN an_DT earlier_JJR study_NN in_IN which_WDT 22_CD of_IN 30_CD (_( 73_CD %_NN )_) of_IN Anaplasma-positive_JJ animals_NNS were_VBD found_VBN to_TO be_VB seropositive_JJ ._SENT An_DT earlier_RBR experimental_JJ needle_NN inoculation_NN trial_NN in_IN sheep_NN with_IN A._NP phagocytophila-infected_JJ blood_NN indicated_VBD that_IN infected_JJ neutrophils_NNS may_MD be_VB found_VBN by_IN Giemsa-stained_NP blood_NN smears_VBZ examination_NN several_JJ days_NNS before_IN seroconversion_NN appears_VBZ ._SENT In_IN addition_NN ,_, some_DT Anaplasma-infected_JJ lambs_NNS have_VBP been_VBN found_VBN to_TO remain_VB seronegative_JJ for_IN up_IN to_TO 6_CD weeks_NNS after_IN the_DT primary_JJ inoculation_NN with_IN a_DT species_NN similar_JJ to_TO the_DT HGE_NP agent_NN ._SENT Serologic_JJ investigation_NN is_VBZ therefore_RB not_RB reliable_JJ as_IN the_DT only_JJ diagnostic_JJ tool_NN to_TO detect_VB acute_JJ Anaplasma_NP infection_NN in_IN sheep_NN ._SENT There_EX has_VBZ been_VBN much_JJ debate_NN about_IN the_DT species_NN definition_NN and_CC nomenclature_NN of_IN the_DT group_NN of_IN granulocytic_JJ Ehrlichia_NP ._SENT Recently_RB ,_, Dumler_NP et_FW al._FW clarified_VBN this_DT by_IN unifying_JJ E._NP phagocytophila_NN ,_, E._NP equi_NP ,_, and_CC the_DT HGE_NP agent_NN into_IN a_DT single_JJ species_NN :_: A._NP phagocytophila_NP ._SENT However_RB ,_, there_EX are_VBP minor_JJ differences_NNS in_IN the_DT 16S_JJ rRNA_NN gene_NN of_IN the_DT latter_JJ species_NN ,_, and_CC these_DT differences_NNS can_MD be_VB used_VBN to_TO differentiate_VB particular_JJ groups_NNS within_IN the_DT species_NN A._NP phagocytophila_NN ._SENT Typing_VBG within_IN species_NNS will_MD require_VB more_JJR polymorphism_NN than_IN the_DT limited_JJ variation_NN found_VBN in_IN the_DT 16S_JJ rRNA_NN gene_NN ._SENT Therefore_RB ,_, analysis_NN of_IN particular_JJ highly_RB polymorphic_JJ sequences_NNS or_CC of_IN a_DT number_NN of_IN housekeeping_NN genes_NNS ,_, such_JJ as_IN those_DT used_VBN in_IN the_DT multilocus_NN sequence_NN typing_VBG ,_, are_VBP required_VBN for_IN reliable_JJ discrimination_NN of_IN strain_NN types_NNS ._SENT Variations_NNS in_IN other_JJ genes_NNS ,_, especially_RB those_DT coding_VBG for_IN surface_NN proteins_NNS ,_, are_VBP more_RBR likely_JJ to_TO affect_VB properties_NNS such_JJ as_IN virulence_NN ,_, host_NN range_NN ,_, and_CC interaction_NN with_IN arthropod_NN vectors_NNS ._SENT Recently_RB ,_, it_PP has_VBZ been_VBN shown_VBN that_DT sera_NN from_IN mice_NNS with_IN high_JJ concentrations_NNS of_IN antibodies_NNS that_WDT bind_VBP to_TO the_DT P44_JJ proteins_NNS of_IN the_DT HGE_NP agent_NN or_CC monoclonal_NN antibodies_NNS specific_JJ to_TO these_DT proteins_NNS partially_RB protect_VB mice_NNS from_IN the_DT infection_NN and_CC that_IN this_DT protein_NN may_MD be_VB located_VBN in_IN the_DT outer_JJ membrane_NN of_IN the_DT HGE_NP agent_NN ._SENT This_DT suggests_VBZ that_IN the_DT P44-protein_NP specific_JJ antibodies_NNS may_MD play_VB a_DT role_NN in_IN the_DT immunity_NN against_IN this_DT infection_NN and_CC that_IN the_DT genes_NNS encoding_VBG the_DT P44_JJ outer_JJ membrane_NN proteins_NNS may_MD have_VB a_DT role_NN in_IN pathogenesis_NN and_CC immunresponse_NN in_IN A._NP phagocytophila_NN infection_NN in_IN mice_NNS ._SENT In_IN conclusion_NN ,_, the_DT present_JJ study_NN shows_VBZ the_DT existence_NN of_IN different_JJ A._NP phagocytophila_NN variants_NNS in_IN sheep_NN :_: within_IN different_JJ flocks_VBZ ,_, within_IN each_DT flock_NN ,_, and_CC also_RB within_IN a_DT single_JJ animal_NN ._SENT Variants_NNS of_IN A._NP phagocytophila_NN causing_VBG TBF_NP in_IN sheep_NN may_MD accordingly_RB exist_VB simultaneously_RB on_IN the_DT same_JJ pasture_NN and_CC may_MD cause_VB differences_NNS in_IN both_DT clinical_JJ and_CC immunosuppressive_JJ reactions_NNS within_IN each_DT flock_NN ._SENT However_RB ,_, the_DT clinical_JJ and_CC epidemiological_JJ consequences_NNS of_IN these_DT findings_NNS have_VBP to_TO be_VB further_RBR elucidated_VBN ._SENT 